187 related articles for article (PubMed ID: 17162222)
1. Molecular and structural basis of portal hypertension.
Moreau R; Lebrec D
Clin Liver Dis; 2006 Aug; 10(3):445-57, vii. PubMed ID: 17162222
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
[TBL] [Abstract][Full Text] [Related]
3. [Experimental observation of high portal venous resistance in dogs].
Wang WM
Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):349-51, 381. PubMed ID: 8258105
[TBL] [Abstract][Full Text] [Related]
4. The pathophysiology of portal hypertension: a basis for classification.
Groszmann RJ; Atterbury CE
Semin Liver Dis; 1982 Aug; 2(3):177-86. PubMed ID: 7178896
[No Abstract] [Full Text] [Related]
5. Etiology and pathophysiology of portal hypertension.
Reichen J
Z Gastroenterol; 1988 Sep; 26 Suppl 2():3-7. PubMed ID: 3055716
[TBL] [Abstract][Full Text] [Related]
6. Portal hypertension: state of the art.
Gatta A; Sacerdoti D; Bolognesi M; Merkel C
Ital J Gastroenterol Hepatol; 1999 May; 31(4):326-45. PubMed ID: 10425579
[TBL] [Abstract][Full Text] [Related]
7. [Portal-systemic shunting and hemodynamics of prehepatic portal hypertensive rat models].
Zhou YB; Leng X; Qi G
Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):244-7. PubMed ID: 10374550
[TBL] [Abstract][Full Text] [Related]
8. [Physiology of the portal system and physiopathology of portal hypertension].
Lebrec D
Rev Prat; 1990 Jun; 40(16):1450-3. PubMed ID: 2193365
[TBL] [Abstract][Full Text] [Related]
9. [Changes in intrahepatic portal systemic shunt flow in a rat model of acute intrahepatic presinusoidal portal hypertension].
Li XN; Shi Y; Ding W
Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):278-81. PubMed ID: 15850516
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic portal hypertension and its pathology.
Okudaira M; Ohbu M; Okuda K
Semin Liver Dis; 2002 Feb; 22(1):59-72. PubMed ID: 11928079
[TBL] [Abstract][Full Text] [Related]
11. [Morpho-functional changes in the vascular bed in obstructed portal blood flow].
Dyskin EA; Gaĭvoronskiĭ IV; Eremenko VP
Vestn Khir Im I I Grek; 1990 May; 144(5):46-50. PubMed ID: 2175983
[TBL] [Abstract][Full Text] [Related]
12. [Circulatory dysfunction syndrome associated with liver cirrhosis].
Hartleb M
Przegl Epidemiol; 2005; 59(2):549-58. PubMed ID: 16190566
[TBL] [Abstract][Full Text] [Related]
13. The pathophysiology of portal hypertension.
Treiber G; Csepregi A; Malfertheiner P
Dig Dis; 2005; 23(1):6-10. PubMed ID: 15920320
[TBL] [Abstract][Full Text] [Related]
14. Modulation of portosystemic shunting by prostacyclin in portal hypertension.
Campbell KA; Wu YP; Sitzmann JV
Curr Surg; 1990; 47(1):17-9. PubMed ID: 2107062
[No Abstract] [Full Text] [Related]
15. The cystic vein as a bypass in portal vein thrombosis. Case report.
Myking AO; Halvorsen JF
Acta Chir Scand; 1971; 137(6):587-91. PubMed ID: 5149392
[No Abstract] [Full Text] [Related]
16. Pharmacological control of portal hypertension.
Polio J; Groszmann RJ
Prog Liver Dis; 1993; 11():231-49. PubMed ID: 8272513
[TBL] [Abstract][Full Text] [Related]
17. [Pathology of portal hypertension (author's transl)].
Tamayo RP
Rev Invest Clin; 1978; 30(1):29-34. PubMed ID: 635320
[No Abstract] [Full Text] [Related]
18. Decreased vascular reactivity of portal vein in rats with portal hypertension.
Huang YT; Lin HC; Yu PC; Lee FY; Tsai YT; Lee SD; Yang MC
J Hepatol; 1996 Feb; 24(2):194-9. PubMed ID: 8907573
[TBL] [Abstract][Full Text] [Related]
19. [Portal hypertension--introduction to the problem].
Brodanová M
Vnitr Lek; 1996 Oct; 42(10):696-9. PubMed ID: 8975461
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular basis of portal hypertension.
Shah V
Clin Liver Dis; 2001 Aug; 5(3):629-44. PubMed ID: 11565134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
